期刊文献+

盐水负荷试验对原发性醛固酮增多症的诊断价值 被引量:5

Diagnostic Value of Saline Infusion Test in Patients With Primary Aldosteronism
下载PDF
导出
摘要 目的:评价盐水负荷试验对于原发性醛固酮增多症(PHA)的诊断价值。方法:回顾性分析1994-06至2012-05我院72例PHA患者(PHA组)和44例排除PHA的原发性高血压(EH)患者(EH组)的临床资料。并应用受试者工作曲线(ROC曲线)对盐水负荷试验前后血浆醛固酮水平及试验后血浆醛固酮/肾素活性比值进行评价,分析其诊断效能,得出最佳诊断切点。结果:试验后血浆醛固酮水平ROC曲线下面积为0.759,敏感性为74.6%,特异性为63.6%。试验后血浆醛固酮/肾素活性比值ROC曲线下面积为0.899,敏感性为83.6%,特异性为88.6%,最佳诊断切点为111[ng/dl:ng/(ml·h)]。结论:盐水负荷试验后血浆醛固酮水平及血浆醛固酮/肾素活性比值,对于PHA均有诊断价值,试验后血浆醛固酮/肾素活性比值诊断效能更高。 Objective: To evaluate the diagnostic value of saline infusion test (SIT) in patients with primary aldosteronism (PHA). Methods: A total of 116 patients with PHA or essential hypertension (EH) treated in our hospital from 1994-06 to 2013- 05 were retrospectively studied. The patients were divided into 2 groups: PHA group, n=72 and EH group, the patients with excluded PHA, n=44. post-SIT plasma levels of aldosterone and post-SIT ratio of aldosterone/renin activity were evaluated by ROC curve in order to analyze the diagnostic capability and the best diagnostic cut-offpoint. Results: The area under curve (AUC) by ROC for post-SIT aldosterone level was 0.759, the sensitivity and specificity were 74.6% and 63.6% respectively; AUC for post-SIT ratio of aldosterone/renin activity was 0.899, the sensitivity and specificity were 83.6% and 88.6% with the best diagnostic cut-offpoint at 111 [ng/dl:ng/(ml.h)]. Conclusion: Post-SIT plasma level of aldosterone and post-SIT ratio of aldosterone/renin activity had the diagnostic value of PHA; post-SIT ratio of aldosterone/renin activity had the higher diagnostic value of PHA.
出处 《中国循环杂志》 CSCD 北大核心 2016年第6期604-605,共2页 Chinese Circulation Journal
关键词 醛固酮增多症 盐水输注试验 诊断 Hyper aldosteronism Saline load test Diagnosis
  • 相关文献

参考文献4

二级参考文献29

  • 1张炜,汤正义,王卫庆,吴景程,张华,宁光.肾上腺静脉采血在原发性醛固酮增多症分型诊断中的应用[J].中华内分泌代谢杂志,2006,22(5):411-413. 被引量:16
  • 2Mulatero P,Stowasser M,Loh KC,et al.Increased diagnosis of primary aldosteronism,ineluding surgically correctable forms,in centers from five continents.J Clin Endocrinol Metab,2004,89:1045-1050.
  • 3Rossi GP,Bernini G,Caliumi C,et al.A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.J Am Coll Cardiol,2006,48:2293-2300.
  • 4Omura M,Saito J,Yamaguchi K,et al.Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.Hypertens Res,2004,27:193-202.
  • 5Fogari R,Preti P,Zoppi A,et al.Prevalence of primary aldosteronism among unselected hypertensive patients:a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.Hypertens Res,2007,30:111 -117.
  • 6Agharazii M,Douville P,Grose JH,et al.Captopril suppression versus salt loading in confirming primary aldosteronism.Hypertension,2001,37:1440-1443.
  • 7Catena C,Colussi G,Nadalini E,et al.Cardiovascular outcomes in patients with primary aldosteronism after treatment.Arch Intern Med,2008,168:80-85.
  • 8Born-Frontsberg E,Reincke M,Rump LC,et al.Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism:results of the German Conn's Registry.J Clin Endocrinol Metab,2009,94:1125-1130.
  • 9Sechi LA,Novello M,Lapenna R,et al.Long-term renal outcomes in patients with primary aldosteronism.JAMA,2006,295:2638-2645.
  • 10Catena C,Lapenna R,Baroselli S,et al.Insulin sensitivity in patients with primary aldosteronism:a follow-up study.J Clin Endocrinol Metab,2006,91:3457-3463.

共引文献53

同被引文献31

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部